Are Peptides FDA-Approved? Which Ones, and What Approval Means
Some peptides are FDA-approved drugs; most compounds sold for research are not. What approval actually means, which peptide drugs hold approvals, and how to check for
Educational, research-only overviews of peptides, blends, testing methods, and how to read the scientific literature. For laboratory and research use only.
Some peptides are FDA-approved drugs; most compounds sold for research are not. What approval actually means, which peptide drugs hold approvals, and how to check for
Peptide is not a legal category. What US law actually says, what the July 2026 FDA advisory committee vote changed, and why a research-use-only label is
GHK-Cu has 179 published papers and, unusually, randomised human trials. Both were topical, and neither showed an objective benefit.
The Wolverine stack is a nickname for combining BPC-157 and TB-500. The one study that tested the combination found it conferred no additional benefit over either
GLOW is a three-peptide research blend of GHK-Cu, BPC-157 and TB-500, totalling 70 mg per vial. What is in it, what the literature examines for each
BPC-157 survives gastric acid, but that is not the same as being absorbed. The bioavailability figures in circulation are intramuscular, from rats and dogs. What the
Weekly peptide research summaries, testing guides, and documentation updates.
TB-500 is the supplier name for a peptide based on thymosin beta-4, an actin-binding protein. What the published Tβ4 research examines, why the two names are
Thymosin alpha-1 is a 28-amino-acid peptide produced by the thymus, studied mainly for immune modulation. What it is, what the literature examines, and what it does
KLOW and GLOW share the same three-peptide base. KLOW adds KPV, taking the vial from 70 mg to 80 mg. A factual, research-only comparison of composition,
Discount Applied Successfully!
Your savings have been added to the cart.